New Delhi, May 12

Bharat Biotech’s Covaxin has received the drug regulatory nod for advance clinical trials on children aged between 2 and 18 years.

The subject expert committee of the Central Drug Standards Control Organisation (CDSCO) said the trials would be conducted on 525 children at various sites, including at AIIMS-New Delhi, AIIMS-Patna and Meditrina Institute of Medical Sciences, Nagpur. — TNS